Healthcare systems fail to deliver at affordable prices finds report

NewsGuard 100/100 Score

According to a new report from Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment, the NHS patients are not getting treatments at affordable process and this is a failure on part of the global health innovation system.

The report is titled, “The People's Prescription: Re-imagining health innovation to deliver public value.” It says that there is a serious hurdle to the health innovation system that is driven by profits. There is little development of drugs and therapies for critical healthcare needs the report says and adds that a major overhaul of the system is needed. Direction as well as rate of innovation is urgent, it says.

On innovation the report explains that at present drug development is short term and involves greater costs and higher risks. It needs to focus on long term research that would probably not yield rapid gains to shareholders but provide critical innovations and advances in healthcare.

The report also states that medicines are coming at higher prices and this can lead to problems of patient accessibility and also damage the total healthcare system. The authors explain that demanding low cost medicines is not the solution but a deeper understanding of how drug advances work is necessary here. It states that corporate governance in medicine advancement is hurting the innovation. The report calls the system “fundamentally broken”.

NHS England for example spent £1bn on medicines last year and drug spending is rising five times the rate of its budget states the report. Priorities must be public health care needs says the report. For example disease like tuberculosis should receive focus when it comes to drug development. Drugs that have received approval in the last few years, state the authors, have provided no additional benefit to the public health.

New drug approval has been compared to the money spent. In the 1950’s the report explains an average of 40 new drugs were work upon using $1bn in research and development. This has come down to 0.65 drugs per $1bn spent in the 21st Century. This means there is a massive decline in investment in new drug development. Most of the pharmaceutical companies are spending the R & D money on short term projects that can provide financial gains in the short term to share holders. No long term benefits to drug innovation are seen consequently.

According to Professor Mariana Mazzucato, “The diagnosis looks bleak for the health innovation system; it's expensive and unproductive and requires a complete transformation. We have a situation now where the NHS is a huge buyer of drugs and the UK government is a significant investor in the development of new treatments, yet big pharmaceutical companies are calling the shots. In the year of the 70th anniversary of the NHS, this is an ideal time to take stock and rethink the system with a move towards a model that prioritises long-term public value above short-term corporate profits.”

The report urges the government to start procuring affordable generic medicines and make sure companies drop medicine prices to make healthcare more affordable. Further vital and critical medicines should be open to innovation.

Source: https://www.ucl.ac.uk/bartlett/public-purpose/sites/public-purpose/files/peoples_prescription_report_final_online.pdf

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, October 15). Healthcare systems fail to deliver at affordable prices finds report. News-Medical. Retrieved on May 18, 2024 from https://www.news-medical.net/news/20181015/Healthcare-systems-fail-to-deliver-at-affordable-prices-finds-report.aspx.

  • MLA

    Mandal, Ananya. "Healthcare systems fail to deliver at affordable prices finds report". News-Medical. 18 May 2024. <https://www.news-medical.net/news/20181015/Healthcare-systems-fail-to-deliver-at-affordable-prices-finds-report.aspx>.

  • Chicago

    Mandal, Ananya. "Healthcare systems fail to deliver at affordable prices finds report". News-Medical. https://www.news-medical.net/news/20181015/Healthcare-systems-fail-to-deliver-at-affordable-prices-finds-report.aspx. (accessed May 18, 2024).

  • Harvard

    Mandal, Ananya. 2018. Healthcare systems fail to deliver at affordable prices finds report. News-Medical, viewed 18 May 2024, https://www.news-medical.net/news/20181015/Healthcare-systems-fail-to-deliver-at-affordable-prices-finds-report.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FUJIFILM Healthcare Europe introduces EndoGel training model for endoscopic procedures